Amgen (AMGN) Announces Positive Results for Phase 3 Study of Bemarituzumab
Amgen Inc. (NASDAQ:AMGN) is one of the 10 Best Dip Stocks to Buy According to Billionaires. On June 30, Amgen Inc.
Amgen Inc (AMGN)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | HealthInvest Partners AB Anders Hallberg And Carl Bennet | 23,894 | $6,671,444 | -11% | 2.86% |
| 2. | Zevenbergen Capital Investments Nancy Zevenbergen | 9,854 | $2,751,335 | +4% | 0.05% |
| 3. | Ayrshire Capital Management John Nevin Jr. | 5,712 | $1,594,987 | +2% | 0.77% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $165.50 | 10 | $1,655.00 | 3,582 | 2015-08-19 | Filing | |
| $166.64 | 3,000 | $499,907.10 | 3,572 | 2015-08-19 | Filing | |
| $152.29 | 1,500 | $228,435.00 | 2,000 | 2015-02-05 | Filing | |
| $152.29 | 1,500 | $228,435.00 | 2,000 | 2015-02-05 | Filing | |
| $111.77 | 894 | $99,919.25 | 185,013 | 2014-05-12 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $289.68 | 1,500 | $434,520.00 | 8,162 | 2025-06-05 | Filing | |
| $279.69 | 1,000 | $279,690.00 | 4,034 | 2025-05-02 | Filing | |
| $292.84 | 8,711 | $2,550,903.11 | 71,546 | 2025-02-19 | Filing | |
| $304.44 | 25,225 | $7,679,524.23 | 36,922 | 2025-02-21 | Filing | |
| $293.22 | 8,711 | $2,554,223.74 | 62,147 | 2025-02-19 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 768,882 | $214,679,542 | 0.24% | |
| 2. | 612,120 | $170,910,027 | 1.7% | |
| 3. | 518,604 | $144,799,423 | 0.21% | |
| 4. | 399,185 | $119,052,898 | 0.2% | |
| 5. | 314,981 | $87,945,845 | 0.79% |
News See All
Piper Sandler Reaffirms Buy on Amgen Amid MariTide Tolerability Update
Amgen Inc. (NASDAQ:AMGN) ranks among the best set-it-and-forget-it stocks to buy. On June 24, Piper Sandler reaffirmed its Overweight rating and $328 price target for Amgen Inc.
10 Best Dip Stocks to Buy According to Billionaires
On July 3rd, Dan Ives, Global Head of Tech Research at Wedbush, joined CNBC to discuss the technology sector.
Amgen (AMGN) Announces Full Results from Part 1 of the Phase 2 study of MariTide
Amgen Inc. (NASDAQ:AMGN) is one of the 10 Best Value Stocks to Buy According to Billionaires.
10 Best Value Stocks to Buy According to Billionaires
The H1 2025 has been a roller coaster ride for the investors. During the initial months of the year, the benchmarks touched record highs, according to Bank of America Private Bank.
15 Set-It-and-Forget-It Stocks to Buy According to Analysts
As expectations for trade agreements and potential rate cuts reduced investor anxiety, the S&P 500 and Nasdaq reached record closing highs on June 30, concluding their strongest quarter in over a year...
11 Stocks Jim Cramer Put Under the Microscope Recently
On Wednesday’s episode of Mad Money, host Jim Cramer shared his thoughts on the notion of whether the current surge in semiconductor stocks could be the modern-day equivalent of the energy boom of the...
Amgen Boosts Growth With Strong Q1 Results and $1.9B Infrastructure Investment
Amgen Inc. (NASDAQ:AMGN) is one of the 15 best stocks to invest in for an 18 year old. Amgen Inc.
Amgen’s Strong Cash Flow Supports Reliable Dividend Payments
The company has built a solid track record of dividend growth, supported by consistent cash generation.
Billionaire Hedge Funds
